Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (4375)	5/28/1998 12:19:00 PM
From: Bhag Karamchandani	Read Replies (1) of 6136

Richard: Thanks for your response. I was away for a few days. I value highly your comments on AGPH and other threads. I see a number of individual longs on this thread and then look at the significant increase in shorts, and the unusually large numbers thereof for over the past 12 months or more,which according to some veterans is usually a sign that the shorts are not merely short term speculators but rather well informed investors. For the sake of the longs I hope this isn't true. Significant wide spread insider selling, when one can borrow against the discounted accrued value of optioned shares, is also not a positive sign. Another slightly paranoid theory: AGPH is being shorted on behalf of a potential acquirer. This is by no means as far fetched as it may first sound. Your comments about Johnson reflect my impressions of him and I have always liked AGPH understated style of communication as opposed to hype. I just hope that AG3340 proves to be as successful as viracept and not another Thymatiq. Why was the latter not farmed out for continued development as an orphan drug? Was it because there were no takers? Cheers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next